Loading ...

Lynn Serizawa

Immune Tolerance Network

Assessment Group

lserizawa@immunetolerance.org

Work:

415 854 7832‬

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN062ST

-

Tolerance by engaging antigen during cellular homeostasis

ITN066AI

-

Type 1 Diabetes Extension Study

ITN075AI

-

Brentuximab Vedotin for Systemic Sclerosis

ITN077AI

-

Best Available Therapy Vs. Autologous Hematopoietic Stem Cell Transplant For MS

ITN080AI

-

Belimumab With Rituximab for Primary Membranous Nephropathy

ITN086AI

-

Evaluation of AMG 714 for Vitiligo

ITN101ST

-

EVR and EPO for Liver Transplant Tolerance

ITN832AI

-

Clinical phase II/III trial of Ustekinumab to treat type 1 diabetes.

Bio:

Admin Links

Shortcuts

ITN Documents

Links